James Ballance
Nessuna posizione attualmente
Profilo
James Ballance worked as a Director of Business Development at Aventis Behring from 1999 to 2001.
He was the Vice President of Scientific Affairs at PhaseBio Pharmaceuticals, Inc. in 2013 and 2014.
He was also the Head of Research and Development at Delta Biotechnology Ltd.
Additionally, he worked as the Vice President of Technology Development at BioRexis Pharmaceutical Corp.
from 2003 to 2007.
Dr. Ballance received his undergraduate degree from the University of Wales (Bangor) in 1981 and his doctorate from the University of Bristol in 1984.
Precedenti posizioni note di James Ballance
| Società | Posizione | Fine |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Chief Tech/Sci/R&D Officer | 01/12/2007 |
| Aventis Behring | Corporate Officer/Principal | 01/01/2001 |
| PHASEBIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The private company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Chief Tech/Sci/R&D Officer | - |
Formazione di James Ballance
| University of Wales (Bangor) | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The private company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
| Aventis Behring | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
- Borsa valori
- Insiders
- James Ballance
